All Articles

Ophthalmic Product Development Insights
Early detection may allow treatment and possible reversal. Part 1 of a 2-part series.
A prospective evaluation of the effects of cyclosporine ophthalmic emulsion 0.05% on ocular surface staining and visual performance in patients with dry eye
Results of a Phase 2 Safety and Efficacy Clinical Study in the Environment and During Challenge in the Controlled Adverse Environment Model
Genetic approaches, stem cells, anti-VEGF therapy, presbyopia among innovative research
A look at the latest research from multiple corners of ophthalmology, from gene therapy to dry eye.
Alcaftadine was significantly more effective than olopatadine in reducing the itching caused by grass pollen at 16 hours after dosing
Putting two drugs together in one formulation can sometimes achieve better results than either agent can by itself.